{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:52:58Z","timestamp":1790905978452,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcte.2026.100442","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:09:28Z","timestamp":1777597768000},"page":"100442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Edoardo","family":"Ruggeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Censi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Bertazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Clausi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Galuppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Pennelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ceolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susi","family":"Barollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2026.100442_b0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2026.100442_b0010","first-page":"137","article-title":"Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30years","volume":"161","author":"Randle","year":"2017","journal-title":"Surgery (United States)"},{"key":"10.1016\/j.jcte.2026.100442_b0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/thy.2014.0277","article-title":"Response to initial therapy predicts clinical outcomes in medullary thyroid cancer","volume":"25","author":"Lindsey","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2026.100442_b0020","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jcte.2026.100442_b0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/oncolo\/oyad232","article-title":"Management of medullary thyroid cancer: patterns of recurrence and outcomes of reoperative surgery","volume":"28","author":"Papachristos","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.jcte.2026.100442_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2023.0482","article-title":"Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma","volume":"34","author":"Censi","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2026.100442_b0035","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1530\/EJE-11-0079","article-title":"Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification","volume":"164","author":"Mian","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2026.100442_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10689-004-7022-3","article-title":"Molecular pathogenesis of MEN2-associated tumors","volume":"4","author":"Koch","year":"2005","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jcte.2026.100442_b0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.isci.2019.09.030","article-title":"Genetic landscape of somatic mutations in a large cohort of sporadic medullary thyroid carcinomas studied by next-generation targeted sequencing","volume":"20","author":"Ciampi","year":"2019","journal-title":"IScience"},{"key":"10.1016\/j.jcte.2026.100442_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-80396-3_1","article-title":"What is new in diagnostics and management of medullary thyroid carcinoma","volume":"223","author":"Raue","year":"2025","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.jcte.2026.100442_b0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.21.01329","article-title":"International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma","volume":"40","author":"Xu","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcte.2026.100442_b0060","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.gim.2022.01.001","article-title":"Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)","volume":"24","author":"Horak","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.jcte.2026.100442_b0065","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1210\/jc.2011-3299","article-title":"Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma","volume":"97","author":"Xu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2026.100442_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081951","article-title":"Medullary thyroid carcinoma mutational spectrum update and signaling-type inference by transcriptional profiles: literature meta-analysis and study of tumor samples","volume":"14","author":"Minna","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcte.2026.100442_b0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cancergen.2021.03.003","article-title":"Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma","volume":"256\u2013257","author":"Torres","year":"2021","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jcte.2026.100442_b0080","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1126\/science.282.5395.1893","article-title":"Linkage of ATM to cell cycle regulation by the Chk2 protein kinase","volume":"282","author":"Matsuoka","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jcte.2026.100442_b0085","article-title":"Metastasis of neuroendocrine tumors are characterized by increased cell proliferation and reduced expression of the ATM gene","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcte.2026.100442_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/361020","article-title":"CDK\/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity","volume":"2014","author":"Bonelli","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jcte.2026.100442_b0095","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/MCB.20.16.6147-6158.2000","article-title":"Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity","volume":"20","author":"Franklin","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jcte.2026.100442_b0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1089\/thy.2016.0224","article-title":"Role of CDKN2C copy number in sporadic medullary thyroid carcinoma","volume":"26","author":"Grubbs","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2026.100442_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nrc3929","article-title":"Hijacked in cancer: the KMT2 (MLL) family of methyltransferases","volume":"15","author":"Rao","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcte.2026.100442_b0110","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcte.2026.100442_b0115","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1126\/science.2116665","article-title":"Two G protein oncogenes in human endocrine tumors","volume":"249","author":"Lyons","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jcte.2026.100442_b0120","article-title":"GNAS mutated thyroid carcinoma in a patient with Mc Cune Albright syndrome","volume":"13","author":"Legrand","year":"2020","journal-title":"Bone Rep"},{"key":"10.1016\/j.jcte.2026.100442_b0125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-06-1125","article-title":"Genetic alterations and their relationship in the phosphatidylinositol 3-kinase\/Akt pathway in thyroid cancer","volume":"13","author":"Hou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcte.2026.100442_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2009.10.016","article-title":"The PI3K-akt-mTOR pathway in initiation and progression of thyroid tumors","volume":"321","author":"Saji","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jcte.2026.100442_b0135","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)62295-X","article-title":"Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K\/AKT pathway: regulation of p27kip1 expression and localization","volume":"166","author":"Motti","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcte.2026.100442_b0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcte.2026.100442_b0145","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-2703","article-title":"Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS","volume":"98","author":"Agrawal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2026.100442_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2007.12.016","article-title":"Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas","volume":"284","author":"Dvorakova","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jcte.2026.100442_b0155","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/thy.2005.15.531","article-title":"RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors","volume":"15","author":"Kouvaraki","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2026.100442_b0160","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1089\/thy.2013.0610","article-title":"Concomitant RAS, RET\/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma","volume":"24","author":"Zou","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2026.100442_b0165","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-1921","article-title":"High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas","volume":"96","author":"Moura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2026.100442_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40618-016-0526-5","article-title":"Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland","volume":"40","author":"Ciampi","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jcte.2026.100442_b0175","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.18632\/oncotarget.23986","article-title":"RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases","volume":"9","author":"Romei","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcte.2026.100442_b0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.2023.0279","article-title":"Association of the genomic profile of medullary thyroid carcinoma with tumor characteristics and clinical outcomes in an international multicenter study","volume":"34","author":"Xu","year":"2024","journal-title":"Thyroid"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462372600013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221462372600013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:43:35Z","timestamp":1783107815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221462372600013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"alternative-id":["S221462372600013X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2026.100442","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2026.100442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100442"}}